Colon cancer used to feel like a worry for later-something to think about decades down the road. Not anymore. An estimated ...

The American Cancer Society released updated guidelines for colorectal cancer screening, adding options for a blood-based ...

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. Colon cancer is a leading cause of cancer-related deaths.

ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

For years, the gold standard in screening for colon cancer has been a colonoscopy. But a colonoscopy is a medical procedure that involves length prep work, along with being put under, making it ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield™ blood test for colorectal cancer screening (CRC) is now covered for eligible UnitedHealth Group ...

Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. This voice experience is generated by AI. Learn more. This ...

As of July 1, Ontarians age 45 and up are eligible to receive the at-home fecal immunochemical screening test — or FIT — that ...

Colon cancer remains a significant health concern, particularly within the Black community, where the disease disproportionately affects individuals. A recent study led by researcher Adjoa ...

The Food and Drug Administration (FDA) has approved a new blood test to detect colon cancer. The blood test, manufactured by Guardant Health’s Shield, does not replace colonoscopies. Colorectal cancer ...

As of July 1, Ontario will offer publicly funded colorectal cancer (CRC) screening to patients as young as 45 years. Patients ...